Taxis Pharmaceuticals

TAXIS Pharmaceuticals is a privately owned biopharmaceutical firm focused on diminishing and potentially eradicating the challenge of existing and emerging antimicrobial resistance across a broad spectrum of infectious ailments. We are presently studying novel categories of anti-resistance agents utilizing unique mechanisms of action different from those currently in medical practice. Our team's proficiency in exploratory chemistry, coupled with our culture of creativity, enables us to promptly identify promising compounds that demonstrate the crucial characteristics necessary for a potential clinical drug candidate.